Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients

Amy D. Shapiro, Margaret V. Ragni, Leonard A. Valentino, Nigel S. Key, Neil C. Josephson, Jerry S Powell, Gregory Cheng, Arthur R. Thompson, Jaya Goyal, Karen L. Tubridy, Robert T. Peters, Jennifer A. Dumont, Donald Euwart, Lian Li, Bengt Hallén, Peter Gozzi, Alan J. Bitonti, Haiyan Jiang, Alvin Luk, Glenn F. Pierce

Research output: Contribution to journalArticlepeer-review

126 Scopus citations

Fingerprint Dive into the research topics of 'Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds